Published in Genes Dev on July 15, 2009
KRAS and YAP1 converge to regulate EMT and tumor survival. Cell (2014) 3.06
Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation. J Clin Invest (2011) 1.97
Small RNA combination therapy for lung cancer. Proc Natl Acad Sci U S A (2014) 1.43
Metabolic shifts in residual breast cancer drive tumor recurrence. J Clin Invest (2017) 1.38
An integrin-ILK-microtubule network orients cell polarity and lumen formation in glandular epithelium. Nat Cell Biol (2013) 1.38
Technologies for deriving primary tumor cells for use in personalized cancer therapy. Trends Biotechnol (2013) 1.15
K-Ras and B-Raf oncogenes inhibit colon epithelial polarity establishment through up-regulation of c-myc. J Cell Biol (2012) 1.00
Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling. Oncogene (2011) 1.00
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions. Oncogene (2011) 0.97
A novel MCF-10A line allowing conditional oncogene expression in 3D culture. Cell Commun Signal (2011) 0.94
Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasias. Oncotarget (2011) 0.92
Stem cell marker prominin-1 regulates branching morphogenesis, but not regenerative capacity, in the mammary gland. Dev Dyn (2011) 0.89
Cadherin 6 is a new RUNX2 target in TGF-β signalling pathway. PLoS One (2013) 0.86
Scribble modulates the MAPK/Fra1 pathway to disrupt luminal and ductal integrity and suppress tumour formation in the mammary gland. PLoS Genet (2014) 0.86
Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties. PLoS One (2015) 0.86
Dual function of Yap in the regulation of lens progenitor cells and cellular polarity. Dev Biol (2013) 0.85
Negative Selection and Chromosome Instability Induced by Mad2 Overexpression Delay Breast Cancer but Facilitate Oncogene-Independent Outgrowth. Cell Rep (2016) 0.79
Stress signaling and the shaping of the mammary tissue in development and cancer. Oncogene (2014) 0.79
The insulin receptor plays an important role in secretory differentiation in the mammary gland. Am J Physiol Endocrinol Metab (2013) 0.79
The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity. BMC Cancer (2015) 0.77
Tumorigenesis: Replicating recurrence. Nat Rev Cancer (2009) 0.75
Genetic disruption of oncogenic Kras sensitizes lung cancer cells to Fas receptor-mediated apoptosis. Proc Natl Acad Sci U S A (2017) 0.75
Progressive polarity loss and luminal collapse disrupt tissue organization in carcinoma. Genes Dev (2017) 0.75
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med (2001) 24.51
Generation of a functional mammary gland from a single stem cell. Nature (2006) 18.30
Purification and unique properties of mammary epithelial stem cells. Nature (2006) 15.98
Cancer. Addiction to oncogenes--the Achilles heal of cancer. Science (2002) 14.20
Putting tumours in context. Nat Rev Cancer (2001) 12.37
Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res (1990) 9.85
Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer (2005) 8.70
Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci U S A (1992) 8.69
Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell (1999) 8.03
The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell (2002) 7.35
Ductal carcinoma in situ of the breast. N Engl J Med (2004) 6.63
Essential role for oncogenic Ras in tumour maintenance. Nature (1999) 6.51
ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol (2001) 6.21
Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci U S A (1991) 5.78
Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol (2002) 5.74
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev (2001) 5.67
Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development (1989) 5.62
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature (2004) 5.61
Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol (2003) 4.53
Endothelial tubes assemble from intracellular vacuoles in vivo. Nature (2006) 4.46
Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell (2002) 4.36
Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat Cell Biol (2003) 4.25
Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci (2002) 4.25
Modeling tissue-specific signaling and organ function in three dimensions. J Cell Sci (2003) 3.52
Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell (1992) 3.37
Cdc42 controls spindle orientation to position the apical surface during epithelial morphogenesis. J Cell Biol (2008) 3.29
Genetic control of single lumen formation in the zebrafish gut. Nat Cell Biol (2007) 3.07
An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J Cell Biol (1998) 3.04
Experimental mammary epithelial morphogenesis in an in vivo model: evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res Treat (1996) 3.00
Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell (1991) 2.78
Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res (2003) 2.55
Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture. Proc Natl Acad Sci U S A (1982) 2.44
Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev (2003) 2.27
New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiate functionally. J Cell Biol (1989) 2.24
Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes. Mol Cell Biol (2005) 2.20
Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma. J Cell Sci (1995) 2.19
Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras. Proc Natl Acad Sci U S A (2008) 2.14
Cell-polarity dynamics controls the mechanism of lumen formation in epithelial morphogenesis. Curr Biol (2008) 2.13
Initial formation of zebrafish brain ventricles occurs independently of circulation and requires the nagie oko and snakehead/atp1a1a.1 gene products. Development (2005) 2.11
The agrin/perlecan-related protein eyes shut is essential for epithelial lumen formation in the Drosophila retina. Dev Cell (2006) 1.86
Sequential pulses of apical epithelial secretion and endocytosis drive airway maturation in Drosophila. Dev Cell (2007) 1.79
The development of a functionally relevant cell culture model of progressive human breast cancer. Semin Cancer Biol (1995) 1.77
Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res (2005) 1.65
The mammary gland "side population": a putative stem/progenitor cell marker? J Mammary Gland Biol Neoplasia (2005) 1.57
Planar spindle orientation and asymmetric cytokinesis in the mouse small intestine. J Histochem Cytochem (2007) 1.37
Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss. J Clin Invest (2008) 1.36
Real-time imaging reveals that noninvasive mammary epithelial acini can contain motile cells. J Cell Biol (2007) 1.32
Oncogenes come of age. Cold Spring Harb Symp Quant Biol (2005) 0.95
Morphogenesis of mouse mammary epithelial cells growing within collagen gels: ultrastructural and immunocytochemical characterization. Cell Differ (1988) 0.94
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A (2004) 33.85
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med (2005) 25.93
A new initiative on precision medicine. N Engl J Med (2015) 16.03
Rescuing US biomedical research from its systemic flaws. Proc Natl Acad Sci U S A (2014) 14.78
The knockout mouse project. Nat Genet (2004) 7.80
Seeding and propagation of untransformed mouse mammary cells in the lung. Science (2008) 5.33
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. Proc Natl Acad Sci U S A (2005) 4.70
Medicine. The need for a global HIV vaccine enterprise. Science (2003) 4.70
Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A (2003) 4.69
Statement on scientific publication and security. Science (2003) 3.04
Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP. Development (2004) 2.84
Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins. Proc Natl Acad Sci U S A (2012) 2.52
Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4. PLoS One (2007) 2.25
Overview of the Alliance for Cellular Signaling. Nature (2002) 2.15
Statement on the consideration of biodefence and biosecurity. Nature (2003) 2.09
Three decades of Wnts: a personal perspective on how a scientific field developed. EMBO J (2012) 1.89
Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of beta-catenin. Proc Natl Acad Sci U S A (2004) 1.89
Uncensored exchange of scientific results. Proc Natl Acad Sci U S A (2003) 1.73
Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models. Proc Natl Acad Sci U S A (2006) 1.60
Epstein-Barr virus: an important vaccine target for cancer prevention. Sci Transl Med (2011) 1.54
Wnt/Wingless signaling through beta-catenin requires the function of both LRP/Arrow and frizzled classes of receptors. BMC Cell Biol (2003) 1.54
Ten years on--the human genome and medicine. N Engl J Med (2010) 1.52
Casein kinase Iepsilon modulates the signaling specificities of dishevelled. Mol Cell Biol (2004) 1.41
Erlotinib resistance in mouse models of epidermal growth factor receptor-induced lung adenocarcinoma. Dis Model Mech (2009) 1.34
Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer. Cancer Discov (2014) 1.27
A protein knockdown strategy to study the function of beta-catenin in tumorigenesis. BMC Mol Biol (2003) 1.26
Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation. Breast Cancer Res (2010) 1.17
Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice. J Clin Invest (2009) 1.17
Requirement for a nuclear function of beta-catenin in Wnt signaling. Mol Cell Biol (2003) 1.14
Assessing tumor progression factors by somatic gene transfer into a mouse model: Bcl-xL promotes islet tumor cell invasion. PLoS Biol (2007) 1.13
DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice. Am J Pathol (2002) 1.12
Wnt-1 is dominant over neu in specifying mammary tumor expression profiles. Technol Cancer Res Treat (2006) 1.10
Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation. Proc Natl Acad Sci U S A (2010) 1.09
Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations. Oncogene (2005) 1.07
Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1. Proc Natl Acad Sci U S A (2012) 1.05
Getting ready for gene-based medicine. N Engl J Med (2002) 1.00
The enlightenment returns. Science (2009) 0.97
Identification and preliminary characterization of novel small molecules that inhibit growth of human lung adenocarcinoma cells. J Biomol Screen (2009) 0.93
Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice. Genome Biol (2005) 0.91
Comparison of expression profiles of metastatic versus primary mammary tumors in MMTV-Wnt-1 and MMTV-Neu transgenic mice. Neoplasia (2008) 0.91
How numbers, nature, and immune status of foxp3(+) regulatory T-cells shape the early immunological events in tumor development. Front Immunol (2013) 0.91
Receptor for hyaluronan-mediated motility isoform B promotes liver metastasis in a mouse model of multistep tumorigenesis and a tail vein assay for metastasis. Proc Natl Acad Sci U S A (2011) 0.88
Activation of PyMT in beta cells induces irreversible hyperplasia, but oncogene-dependent acinar cell carcinomas when activated in pancreatic progenitors. PLoS One (2009) 0.87
Support for the Human Cancer Genome Project. Science (2005) 0.86
Newsmaker interview: Harold Varmus. Piloting cancer research with a shrinking budget. Interview by Jocelyn Kaiser. Science (2011) 0.78
Analysis of PTEN mutation in non-familial pheochromocytoma. Ann N Y Acad Sci (2006) 0.76
NIH funds support more than a researcher's own lab. Nature (2008) 0.75
Progress toward public access to science. PLoS Biol (2008) 0.75
Re-aim blame for NIH's hard times. Science (2006) 0.75
Methods to study primary tumor cells and residual tumor cells in mouse models of oncogene dependence. Methods Mol Biol (2015) 0.75
NIH cancer chief wants more with less: by Meredith Wadman. Nature (2011) 0.75
Varmus Returns to His Roots in Cancer Genetics. JAMA (2015) 0.75
Harold Varmus. Interview by Errol C. Friedberg. Nat Rev Mol Cell Biol (2008) 0.75
A conversation with Harold Varmus. Interview by Ushma S. Neill. J Clin Invest (2012) 0.75
The weaknesses of science for profit. Oncologist (2002) 0.75
A Prize for Cancer Prevention. Cell (2017) 0.75